TP53 and neoplasm: Treatment with this polyphenol induces deacetylation of known SIRT1 substrates such as NF-κB, PGC-1α, and p53, and can mimic the anti-apoptotic and anti-tumor activity of SIRT1 [21], [48]–[51].